Regulation of nicotinic receptor subtypes following chronic nicotinic agonist exposure in M10 and SH-SY5Y neuroblastoma cells

Journal of Neurochemistry

Volumn 70, Issue 5, 1998, Pages 2028-2037

  Warpman, Ulrika ^a,b   Friberg, Linda ^a   Gillespie, Alison ^c   Hellström Lindahl, Ewa ^a   Zhang, Xiao ^a   Nordberg, Agneta ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c SIBIA Corp   (United States)

Author keywords

Epibatidine; M10 cells; mRNA; Neuronal nicotinic receptors; SH SY5Y cells; Up regulation

Indexed keywords

3 METHYL 5 (1 METHYL 2 PYRROLIDINYL)ISOXAZOLE; 4 ACETYL 1,1 DIMETHYLPIPERAZINIUM IODIDE; CARBACHOL; EPIBATIDINE; MESSENGER RNA; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; PIPERAZINE DERIVATIVE; RECEPTOR SUBTYPE; TRITIUM;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BINDING SITE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DEGENERATIVE DISEASE; GENE EXPRESSION REGULATION; MEMORY; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING;

ANIMALIA; TRITIUM;

EID: 0031958699     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.70052028.x     Document Type: Article

References (39)

1. Arneric S., Sullivan J., Briggs C., Donnelly-Roberts D., Andersson D., Raszkiewics H., Hughes M., Cadman E., Adams P., Garvey D., Wasicak J., and Williams M. (1994) ABT 418: a novel cholinergic ligand with cognition enhancing and anxiolytic activities: I. In vitro characterization. J. Pharmacol. Exp. Ther. 270, 310-318.
2. Bencherif M., Fowler K., Lukas R., and Lipiello P. (1995) Mechanisms of up-regulation of neuronal nicotinic acetylcholine receptors in clonal cell lines and primary cultures of fetal rat brain. J. Pharmacol. Exp. Ther. 275, 987-994.
3. 3H]-nicotine binding sites in human brain. J. Neurochem. 50, 1243-1247.
4. Bhat R. V., Turner S. L., Selvaag S. R., Marks M. J., and Collins A. C. (1991) Regulation of brain nicotinic receptors by chronic agonist infusion. J. Neurochem. 56, 1932-1939.
5. Brioni J., Decker M., Sullivan J., and Arneric A. (1997) The pharmacology of (-)-nicotine and novel cholinergic channel modulators Adv. Pharmacol. 37, 153-214.
6. Chomczynski P. and Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
7. Flores C., Rogers S., Pabreza L., Wolfe B., and Kellar K. (1992) A subtype of nicotinic cholinergic receptor in rat brain is composed of α-4 and β-2 subunits and is up-regulated by chronic nicotine treatment. Mol. Pharmacol. 41, 31-37.
8. Garcha H. S., Thomas P., Spivak C. E., Wonnacott S., and Stolerman I. (1993) Behavioural and ligand-binding studies in rats with 1-acetyl-4-methylpiperazine, a novel nicotinic agonist. Psychopharmacology (Berl.) 110, 347-354.
9. Gerzanich V., Peng X., Wang F., Wells G., Anand R., Fletcher S., and Lindstrom J. (1995) Comparative pharmacology for neuronal nicotinic acetylcholine receptors. Mol. Pharmacol. 48, 774-782.
10. Gopalakrishnan M., Monteggia L., Anderson D., Molinari E., Piattoni-Kaplan M., Donnelly-Roberts D., Arneric S., and Sullivan J. (1996) Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine α4β2 receptor. J. Pharmacol. Exp. Ther. 276, 289-297.
11. 3H] epibatidine binding to nicotinic cholinergic receptors in rat and human brain. Mol. Pharmacol. 48, 280-287.
12. Hsu Y.-N., Amin J., Weiss D. S., and Wecker L. (1996) Sustained nicotine exposure differentially affects α3β2 and α4β2 neuronal nicotinic receptors expressed in Xenopus oocytes. J. Neurochem. 66, 667-675.
13. Lambert J. J., Volle R. L., and Hendersson E. G. (1980) An attempt to distinguish between the actions of neuromuscular blocking drugs on the acetylcholine receptor and on its associated channel. Proc. Natl. Acad. Sci. USA 77, 5003-5007.
14. 3H] methylcarbamylcholine binding sites in the rat brain. J. Neurochem. 52, 483-491.
15. Levin E. D. (1992) Nicotinic system and cognitive function. Psychopharmacology (Berl.) 108, 417-431.
16. Liu C., Nordberg A., and Zhang X. (1996) Differential co-expression of nicotinic acetylcholine receptor α4 and β2 subunit genes in various regions of rat brain. Neuroreport 1, 1645-1649.
17. Lowry O. H., Rosebrough N. J., Farr A. L., and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
18. Lukas R. (1995) Diversity and patterns of regulation of nicotinic receptor subtypes. Ann. NY Acad. Sci. 757, 153-168.
19. Lukas R., Norman S., and Lucero L. (1993) Characterization of nicotinic acetylcholine receptors expressed by cells of the SH-SY5Y human neuroblastoma clonal line. Mol. Cell. Neurosci. 4, 1-12.
20. Madhok T., Matta S., and Sharp B. (1995) Nicotine regulates nicotinic cholinergic receptors and subunit mRNAs in PC12 cells through protein kinase A. Mol. Brain Res. 32, 143-150.
21. Marks M., Pauly J., Gross S., Deneris E., Hermans-Borgmeyer I., Heinemann S., and Collins A. (1992) Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J Neurosci. 12, 2765-2784.
22. + efflux from mouse thalamic synaptosomes. J. Pharmacol. Exp. Ther. 277, 1383-1396.
23. Newhouse P., Potter A., Corwin J., and Lenox R. (1994) The role of nicotinic system in the cognitive disorder of Alzheimer's disease, in Alzheimer's Disease: Therapeutic Strategies (Giacobini E. and Becker R., eds), pp. 191-196. Birkhäuser, Boston.
24. Nordberg A. (1994) Human nicotinic receptors - their role in aging and dementia. Neurochem. Int. 25, 93-97.
25. Papke R. (1993) The kinetic properties of neuronal nicotinic receptors: genetic basis of functional diversity. Prog. Neurobiol. 41, 509-531.
26. Pauly J., Marks M., Robinson S., Kamp J. V. D., and Collins A. (1996) Chronic nicotine and mecamylamine treatment increase brain nicotinic receptor binding without changing α4 or β2 mRNA levels. J. Pharmacol. Exp. Ther. 278, 361-369.
27. Peng X., Gerzanich V., Anand R., Whiting P., and Lindstrom J. (1994) Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover. Mol. Pharmacol. 46, 523-530.
28. Peng X., Gerzanich V., Anand R., Wang F., and Lindstrom J. (1997) Chronic nicotine treatment up-regulates α3 and α7 acetylcholine receptor subtypes expressed by the human neuroblastoma cell line SH-SY5Y. Mol. Pharmacol. 51, 776-784.
29. Romanelli L., O̊hman B., Adem A., and Nordberg A. (1988) Subchronic treatment of rat with nicotine: interconversion of nicotine receptor subtypes in brain. Eur. J. Pharmacol. 148, 289-291.
30. Sanderson E. M., Drasdo A. L., McCrea K., and Wonnacott S. (1993) Upregulation of nicotinic receptors following continuous infusion of nicotine is brain region specific. Brain Res. 617, 349-352.
31. Sargent P. B. (1993) The diversity of neuronal nicotinic acetylcholine receptors. Annu. Rev. Neurosci. 16, 403-443.
32. 3H]-acetylcholine recognition sites in brain by nicotinic cholinergic drugs. J. Neurochem. 45, 427-433.
33. Sullivan J., Decker M., Brioni J., Donnelly-Roberts D., Anderson D., Bannon A., Kang C. H., Adams P., Piattoni-Kaplan M., Buckley M., Gopalakrishnan M., Williams M., and Arneric S. (1994) (±)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors. J. Pharmacol. Exp. Ther. 271, 624-631.
34. Wang F., Gerzanich V., Wells G., Anand R., Peng X., Keyser K., and Lindstrom J. (1996) Assembly of human nicotinic receptor α5 subunits with α3, β2 and β4 subunits. J. Biol. Chem. 271, 17656-17665.
35. Whiting P., Schoepfer R., Lindstrom J., and Priestly T. (1991) Structural and pharmacological characterization of the major brain nicotinic acetylcholine receptor subtype stably expressed in mouse fibroblasts. Mol. Pharmacol. 40, 463-472.
36. Wonnacott S. (1990) The paradox of nicotinic receptor up-regulation by nicotine. Trends Pharmacol. Sci. 11, 216-219.
37. Wonnacott S., Drasdo A., Sanderson E., and Rowell P. (1990) Presynaptic nicotinic receptors and the modulation of transmitter release, in CIBA Foundation Symposium 152: The Biology of Nicotine Dependence, pp. 87-105. John Wiley & Sons, Chichester.
38. Yang X. and Buccafusco J. (1994) Effect of chronic central treatment with the acetylcholine analog methylcarbamylcholine on cortical nicotinic receptors: correlation between receptor changes and behavioural function. J. Pharmacol. Exp. Ther. 271, 651-659.
39. Zhang X., Gong Z., Hellström-Lindahl E., and Nordberg A. (1995) Regulation of α4β2 nicotinic acetylcholine receptors in M10 cells following treatment with nicotinic agents. Neuroreport 6, 313-317.